🧠AI AnalysisViking Therapeutics and the Clinical Milestones Shaping Its 2028 Outlook
Viking Therapeutics is advancing multiple late-stage trials for its flagship drug candidate, VK2735, with critical readouts anticipated between 2027 and 2028 that could h…